A case report of apatinib in treating osteosarcoma with pulmonary metastases

RATIONALE: Osteosarcoma is the most common malignant bone tumor in children and adolescents. Pulmonary metastases lead to a significantly increased risk of death. Apatinib, a new potent oral small-molecule tyrosine kinase inhibitor targeting the intracellular domain of vascular endothelial growth fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yong, Zhang, Wengeng, Tang, Fan, Luo, Yi, Min, Li, Zhang, Wenli, Shi, Rui, Duan, Hong, Tu, Chongqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403083/
https://www.ncbi.nlm.nih.gov/pubmed/28403086
http://dx.doi.org/10.1097/MD.0000000000006578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403083/
https://www.ncbi.nlm.nih.gov/pubmed/28403086
http://dx.doi.org/10.1097/MD.0000000000006578

Ejemplares similares